Patient, disease, and transplantation characteristics (N = 205)
| Characteristic . | Value . |
|---|---|
| Median age at transplantation, y (range) | 38 (6-68) |
| Sex, no. (% male) | 103 (50) |
| Sex of donor/patient pair | |
| Female/male | 51 (25) |
| Others | 154 (75) |
| HLA matching, no. (%) | |
| HLA-identical sibling | 69 (34) |
| One HLA haplotype-mismatched family member | 136 (66) |
| Underlying disease, no. (%) | |
| Acute leukemia | 146 (71) |
| Lymphoma/myeloma | 47 (23) |
| Chronic leukemia | 12 (6) |
| Advanced disease stage, no. (%) | 137 (67) |
| Conditioning regimen, no. (%) | |
| With TBI | 153 (75) |
| Without TBI | 52 (25) |
| CMV serology of donor and recipient, no. (%) | |
| CMV−/CMV− | 20 (10) |
| CMV−/CMV+, CMV+/CMV+, or CMV+/CMV− | 185 (90) |
| GVHD, grade II to IV, no. (%) | 11 (5) |
| Invasive aspergillosis, no. (%) | |
| Proven | 19 (9) |
| Probable | 20 (10) |
| Possible | 26 (13) |
| Characteristic . | Value . |
|---|---|
| Median age at transplantation, y (range) | 38 (6-68) |
| Sex, no. (% male) | 103 (50) |
| Sex of donor/patient pair | |
| Female/male | 51 (25) |
| Others | 154 (75) |
| HLA matching, no. (%) | |
| HLA-identical sibling | 69 (34) |
| One HLA haplotype-mismatched family member | 136 (66) |
| Underlying disease, no. (%) | |
| Acute leukemia | 146 (71) |
| Lymphoma/myeloma | 47 (23) |
| Chronic leukemia | 12 (6) |
| Advanced disease stage, no. (%) | 137 (67) |
| Conditioning regimen, no. (%) | |
| With TBI | 153 (75) |
| Without TBI | 52 (25) |
| CMV serology of donor and recipient, no. (%) | |
| CMV−/CMV− | 20 (10) |
| CMV−/CMV+, CMV+/CMV+, or CMV+/CMV− | 185 (90) |
| GVHD, grade II to IV, no. (%) | 11 (5) |
| Invasive aspergillosis, no. (%) | |
| Proven | 19 (9) |
| Probable | 20 (10) |
| Possible | 26 (13) |